Clarity Pharmaceuticals Revenue

In the fiscal year ending June 30, 2024, Clarity Pharmaceuticals had annual revenue of 11.51M AUD with 17.41% growth. Clarity Pharmaceuticals had revenue of 6.09M in the half year ending June 30, 2024, with 66.73% growth.

Revenue

11.51M

Revenue Growth

+17.41%

P/S Ratio

166.41

Revenue / Employee

230.13K

Employees

Market Cap

2.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	11.51M	1.71M	17.41%
Jun 30, 2023	9.80M	3.34M	51.74%
Jun 30, 2022	6.46M	3.26M	102.06%
Jun 30, 2021	3.20M	407.65K	14.62%
Jun 30, 2020	2.79M	145.32K	5.50%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CSL Limited	22.18B
ResMed Inc.	6.93B
Pro Medicus Limited	161.50M
Fisher & Paykel Healthcare Corporation Limited	1.60B
Cochlear Limited	2.24B
Sonic Healthcare Limited	8.97B
Ramsay Health Care Limited	16.66B
Telix Pharmaceuticals Limited	645.68M

Revenue Rankings

Clarity Pharmaceuticals News

24 days ago - Rising Shares at Clarity Pharmaceuticals as it Launches Second Phase III Trial and Promotes Michelle Parker to CEO - CEOWORLD magazine
3 months ago - Three ASX companies jockeying to be the next biotech winners - The Australian Financial Review

More News